Markus Zeitlinger - Concepedia

Author

Markus Zeitlinger

Also Known As

Julia Lumbroso, M ZEITLINGER, M Zeitlinger, M. A. Zeitlinger, M. Zeitlinger, M.A. Zeitlinger, MA Zeitlinger, Marie K. Zeitlinger, Marie Zeitlinger, Markus A. Zeitlinger

456

Publications

9.8K

Citations

H-Index

139

Concepts

All Affiliations

Medical University of Vienna University of Vienna Austrian Institute of Technology Freie Universität Berlin Vienna General Hospital

About

Markus Zeitlinger is an author at Medical University of Vienna specializing in medicine, pharmacology, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	55	2.7K
2	Health Sciences	15	18	990
3	Engineering	2	2	52
4	Education	1	1	18
5	Natural Sciences	1	1	34

Markus Zeitlinger

182

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu, The Lancet Infectious Diseases AntibioticsRespiratory InfectionSepsisExtended-infusion MeropenemNon-inferiority Trial	2020	432
Dexmedetomidine as an adjuvant to ropivacaine prolongs peripheral nerve block: a volunteer study Daniela Marhofer, Stephan C. Kettner, Peter Marhofer, British Journal of Anaesthesia Pain ResearchPeripheral NervesHealth SciencesVolunteer StudyPain Medicine	2012	289
Dislocation rates of perineural catheters: a volunteer study Daniela Marhofer, Peter Marhofer, L. Triffterer, British Journal of Anaesthesia MedicinePatient SafetyPerioperative SafetySurgeryVascular Access	2013	132
Magnetic Resonance Imaging Analysis of the Spread of Local Anesthetic Solution after Ultrasound-guided Lateral Thoracic Paravertebral Blockade Daniela Marhofer, Peter Marhofer, Stephan C. Kettner, Anesthesiology	2013	123
Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy Peter Matzneller, Shaip Krasniqi, Martina Kinzig, Antimicrobial Agents and Chemotherapy	2013	123
Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data Martin Bauer, Markus Zeitlinger, Rudolf Karch, Clinical Pharmacology & Therapeutics	2011	118
A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (<i>R</i>)-<sup>11</sup>C-Verapamil and PET Cláudia Wagner, Martin Bauer, Rudolf Karch, Journal of Nuclear Medicine	2009	111
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response Ulrich Jäger, Michael Fridrik, Markus Zeitlinger, Haematologica	2012	105
Minimal local anaesthetic volumes for sciatic nerve block: evaluation of ED99 in volunteers Daniela Latzke, Peter Marhofer, Markus Zeitlinger, British Journal of Anaesthesia Peripheral Nerve InjurySciatic Nerve BlockPostoperative Pain ManagementLocal Anesthetic PharmacologyPain Management	2009	105
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentDose-escalation Phase 1/2Vaccine Research	2013	100

Page 1